Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999-2009
about
Lack of artemisinin resistance in Plasmodium falciparum in northwest Benin after 10 years of use of artemisinin-based combination therapyA systematic review of the efficacy of a single dose artemisinin-naphthoquine in treating uncomplicated malariaPolymorphisms in K13 and Falcipain-2 Associated with Artemisinin Resistance Are Not Prevalent in Plasmodium falciparum Isolated from Ugandan ChildrenGenetically Determined Response to Artemisinin Treatment in Western Kenyan Plasmodium falciparum ParasitesTemporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya.Uncomplicated Clinical Malaria Features, the Efficacy of Artesunate-Amodiaquine and Their Relation with Multiplicity of Infection in the Democratic Republic of Congo.Artesunate treatment of severe pediatric malaria: A review of parasite clearance kinetics and clinical implications.Haemoglobin changes and risk of anaemia following treatment for uncomplicated falciparum malaria in sub-Saharan Africa.Insight into k13-propeller gene polymorphism and ex vivo DHA-response profiles from Cameroonian isolates.Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination TherapyComparison of anti-malarial drugs efficacy in the treatment of uncomplicated malaria in African children and adults using network meta-analysis.In Vivo Efficacy of Artesunate/Sulphadoxine-Pyrimethamine versus Artesunate/Amodiaquine in the Treatment of Uncomplicated P. falciparium Malaria in Children around the Slope of Mount Cameroon: A Randomized Controlled Trial.Malaria parasite clearance from patients following artemisinin-based combination therapy in Côte d'Ivoire
P2860
Q26209187-D3F60E7B-02CF-4B41-8C88-B049ABE92D6CQ26786586-6349A656-FA4E-422B-ACED-66C483B7E1E2Q27861962-F4AA9122-F8B1-4C49-A0AF-17A05E1D8D46Q28554000-54D54206-6A7E-450C-B66B-026EE999C415Q35849636-0C179470-D285-4C0B-B884-5398195DFE9AQ36046765-A80398BB-7DD6-4A95-8637-C8D7EE630FE0Q36277347-DE25E5A0-6706-4803-931A-9A79C6C1BB58Q36413462-D6D3BA45-D11F-4F48-948F-834C55EF67E0Q37442801-F3F8B44E-1D09-45C9-BAF9-B6C024451D3CQ37538729-63F29AF0-1954-4B9C-B4D2-684942E2B06AQ38642887-03FEA665-E0CB-4406-8CD2-48FD4DCE3D29Q53772614-631BEACC-13CA-46CD-AD56-4051A1198B18Q59126227-99919F1B-BD8E-4B55-8EDB-88400534CF9F
P2860
Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999-2009
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Plasmodium falciparum clearanc ...... sub-Saharan Africa, 1999-2009
@en
Plasmodium falciparum clearanc ...... sub-Saharan Africa, 1999-2009.
@nl
type
label
Plasmodium falciparum clearanc ...... sub-Saharan Africa, 1999-2009
@en
Plasmodium falciparum clearanc ...... sub-Saharan Africa, 1999-2009.
@nl
prefLabel
Plasmodium falciparum clearanc ...... sub-Saharan Africa, 1999-2009
@en
Plasmodium falciparum clearanc ...... sub-Saharan Africa, 1999-2009.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Plasmodium falciparum clearanc ...... sub-Saharan Africa, 1999-2009
@en
P2093
Andreas Mårtensson
Corine Karema
Philippe Brasseur
Umberto d'Alessandro
P2860
P2888
P356
10.1186/1475-2875-13-114
P50
P577
2014-03-25T00:00:00Z
P5875
P6179
1019819818